• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

形成雌激素受体诱饵结合位点的DNA损伤剂的合成与生物活性

Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.

作者信息

Rink S M, Yarema K J, Solomon M S, Paige L A, Tadayoni-Rebek B M, Essigmann J M, Croy R G

机构信息

Department of Chemistry, Massachusetts Institute of Technology, Cambridge 02139, USA.

出版信息

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15063-8. doi: 10.1073/pnas.93.26.15063.

DOI:10.1073/pnas.93.26.15063
PMID:8986764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC26356/
Abstract

It is a goal of cancer chemotherapy to achieve the selective killing of tumor cells while minimizing toxicity to normal tissues. We describe the design of selective toxins forming DNA adducts that attract the estrogen receptor (ER), a transcription factor that is overexpressed in many human breast and ovarian tumors. The compounds consist of 4-(3-aminopropyl)-N,N-(2-chloroethyl)-aniline linked to 2-(4'-hydroxyphenyl)-3-methyl-5-hydroxy-indole. The former moiety is a DNA damaging nitrogen mustard and the latter is a ligand for the ER. The connection between these groups was refined to permit DNA adducts formed by the mustard portion of the molecule to present the ligand domain so that it was able to interact efficiently with the ER. By using 16-mers containing specific DNA adducts, it was determined that monoadducts and putative intrastrand crosslinks were preferred targets for the ER over interstrand crosslinks. A series of structurally related 2-phenylindole mustards was prepared, some of which were selectively toxic to the ER-positive breast cancer cell line MCF-7, as compared with the ER(-) negative line MDA-MB231. The ability both to bind to DNA and to interact significantly with the ER were essential to achieve selective lethality toward ER(+) cells. Compounds forming DNA adducts without the ability to bind receptor showed similar toxicities in the two cell lines. Several models could explain the selective toxicity of the mustard-phenylindole compounds toward ER(+) cells. The favored model suggests that a mustard-DNA adduct is shielded by the ER from DNA repair enzymes and hence cells possessing an abundance of the ER selectively retain the adduct and are killed.

摘要

癌症化疗的一个目标是实现对肿瘤细胞的选择性杀伤,同时将对正常组织的毒性降至最低。我们描述了一种选择性毒素的设计,该毒素形成吸引雌激素受体(ER)的DNA加合物,雌激素受体是一种在许多人类乳腺癌和卵巢肿瘤中过度表达的转录因子。这些化合物由与2-(4'-羟基苯基)-3-甲基-5-羟基吲哚相连的4-(3-氨基丙基)-N,N-(2-氯乙基)-苯胺组成。前一部分是一种DNA损伤性氮芥,后一部分是ER的配体。对这些基团之间的连接进行了优化,以使由分子的氮芥部分形成的DNA加合物呈现配体结构域,从而使其能够与ER有效相互作用。通过使用含有特定DNA加合物的16聚体,确定单加合物和推定的链内交联是ER相对于链间交联更倾向的靶点。制备了一系列结构相关的2-苯基吲哚氮芥,其中一些与ER(-)阴性细胞系MDA-MB231相比,对ER阳性乳腺癌细胞系MCF-7具有选择性毒性。与DNA结合并与ER显著相互作用的能力对于实现对ER(+)细胞的选择性杀伤至关重要。形成DNA加合物但无结合受体能力的化合物在两种细胞系中表现出相似的毒性。有几种模型可以解释氮芥-苯基吲哚化合物对ER(+)细胞的选择性毒性。最受青睐的模型表明,氮芥-DNA加合物被ER屏蔽,免受DNA修复酶的作用,因此拥有大量ER的细胞选择性地保留加合物并被杀死。

相似文献

1
Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.形成雌激素受体诱饵结合位点的DNA损伤剂的合成与生物活性
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15063-8. doi: 10.1073/pnas.93.26.15063.
2
Design, synthesis, and evaluation of estradiol-linked genotoxicants as anti-cancer agents.作为抗癌剂的雌二醇连接的遗传毒性物质的设计、合成与评估。
Bioorg Med Chem Lett. 2004 Jul 16;14(14):3829-33. doi: 10.1016/j.bmcl.2004.04.064.
3
A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells.一种经过合理设计的基因毒素,可选择性地破坏雌激素受体阳性乳腺癌细胞。
J Am Chem Soc. 2002 Mar 6;124(9):1862-3. doi: 10.1021/ja017344p.
4
Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.靶向DNA的4-苯胺基喹啉苯胺氮芥的序列选择性、交联效率和细胞毒性。
Anticancer Drug Des. 1999 Jun;14(3):187-204.
5
Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activity.他利莫司汀苯并杂环类似物的苯甲酰基和肉桂酰基氮芥衍生物:合成与抗肿瘤活性
Bioorg Med Chem. 2002 May;10(5):1611-8. doi: 10.1016/s0968-0896(01)00425-4.
6
A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor.一种双功能铂(II)抗肿瘤剂,可形成对雌激素受体具有亲和力的DNA加合物。
J Inorg Biochem. 2009 Feb;103(2):256-61. doi: 10.1016/j.jinorgbio.2008.10.013. Epub 2008 Oct 26.
7
Relationships between structure, toxicity and genetic effects in Salmonella typhimurium and Saccharomyces cerevisiae for substituted aniline mustards.
Mutat Res. 1989 Sep;224(1):95-104. doi: 10.1016/0165-1218(89)90008-6.
8
Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines.新型酪氨酸-氮芥杂合分子的设计,对子宫、卵巢和乳腺癌细胞系有效。
Steroids. 2012 Apr;77(5):403-12. doi: 10.1016/j.steroids.2011.12.021. Epub 2011 Dec 29.
9
Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: discovery of an unusual structure-activity relationship.用于选择性靶向表皮生长因子受体过表达实体瘤的新型氮芥武装组合分子:一种不寻常构效关系的发现
J Med Chem. 2007 May 31;50(11):2605-8. doi: 10.1021/jm070144p. Epub 2007 May 2.
10
Nitroimidazole-based "extruded mustards' designed as reductively activated hypoxia-selective cytotoxins.基于硝基咪唑的“挤压型芥子气”被设计为还原激活的缺氧选择性细胞毒素。
Anticancer Drug Des. 1996 Jul;11(5):383-402.

引用本文的文献

1
Manipulating RKIP reverses the metastatic potential of breast cancer cells.操控RKIP可逆转乳腺癌细胞的转移潜能。
Front Oncol. 2023 Jul 4;13:1189350. doi: 10.3389/fonc.2023.1189350. eCollection 2023.
2
Drug conjugates-an emerging approach to treat breast cancer.药物偶联物——一种治疗乳腺癌的新兴方法。
Pharmacol Res Perspect. 2018 Jul 5;6(4):e00417. doi: 10.1002/prp2.417. eCollection 2018 Jul.
3
Toward hypoxia-selective DNA-alkylating agents built by grafting nitrogen mustards onto the bioreductively activated, hypoxia-selective DNA-oxidizing agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).致力于通过将氮芥嫁接到生物还原激活的、缺氧选择性DNA氧化试剂3-氨基-1,2,4-苯并三嗪1,4-二氧化物(替拉扎明)上构建缺氧选择性DNA烷基化试剂。
J Org Chem. 2014 Aug 15;79(16):7520-31. doi: 10.1021/jo501252p. Epub 2014 Jul 25.
4
Targeting the androgen receptor with steroid conjugates.用甾体缀合物靶向雄激素受体。
J Med Chem. 2014 Oct 23;57(20):8224-37. doi: 10.1021/jm500101h. Epub 2014 Jul 8.
5
Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs.过氧化氢诱导的 DNA 交联剂:靶向抗癌前药。
J Am Chem Soc. 2011 Dec 7;133(48):19278-81. doi: 10.1021/ja2073824. Epub 2011 Nov 10.
6
Probing the topological tolerance of multimeric protein interactions: evaluation of an estrogen/synthetic ligand for FK506 binding protein conjugate.探究多聚体蛋白相互作用的拓扑容差:FK506 结合蛋白缀合物的雌激素/合成配体的评估。
Bioconjug Chem. 2010 Oct 20;21(10):1880-9. doi: 10.1021/bc100266v.
7
Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One.双功能小分子的设计与应用:为何两个“脑袋”比一个好。
ACS Chem Biol. 2008 Nov 21;3(11):677-692. doi: 10.1021/cb8001792.
8
Tethered indoles as functionalizable ligands for the estrogen receptor.作为雌激素受体可功能化配体的拴系吲哚。
Bioorg Med Chem Lett. 2009 Jan 15;19(2):485-8. doi: 10.1016/j.bmcl.2008.11.043. Epub 2008 Nov 18.
9
Improved biochemical strategies for targeted delivery of taxoids.用于靶向递送紫杉烷类化合物的改进生化策略。
Bioorg Med Chem. 2007 Jun 1;15(11):3597-623. doi: 10.1016/j.bmc.2007.03.041. Epub 2007 Mar 18.
10
Engineering small molecule specificity in nearly identical cellular environments.在几乎相同的细胞环境中设计小分子特异性。
Bioorg Med Chem Lett. 2007 May 15;17(10):2703-5. doi: 10.1016/j.bmcl.2007.03.012. Epub 2007 Mar 12.

本文引用的文献

1
Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth-inhibitory activity in human breast cancer cells.新型雄激素连接的磷酰胺氮芥前药的合成及其对人乳腺癌细胞的生长抑制活性
Anticancer Drug Des. 1995 Dec;10(8):655-66.
2
The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast.HMG结构域蛋白Ixr1阻断酵母中顺铂-DNA加合物的切除修复。
Mutat Res. 1996 Jan 2;362(1):75-86. doi: 10.1016/0921-8777(95)00037-2.
3
Uracil-DNA glycosylase as a probe for protein--DNA interactions.尿嘧啶-DNA糖基化酶作为蛋白质与DNA相互作用的探针。
Nucleic Acids Res. 1993 Jul 25;21(15):3437-43. doi: 10.1093/nar/21.15.3437.
4
Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin.Ixr1是一种酵母蛋白,它能与铂化DNA结合并赋予对顺铂的敏感性。
Science. 1993 Jul 30;261(5121):603-5. doi: 10.1126/science.8342024.
5
Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies.49例患有24种不同类型恶性肿瘤患者队列白细胞DNA中的铂-DNA加合物。
Cancer Res. 1993 Aug 15;53(16):3694-9.
6
Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).顺铂-DNA加合物是核糖体RNA转录因子hUBF(人类上游结合因子)的分子诱饵。
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5672-6. doi: 10.1073/pnas.91.12.5672.
7
A novel role for DNA photolyase: binding to DNA damaged by drugs is associated with enhanced cytotoxicity in Saccharomyces cerevisiae.DNA光解酶的一种新作用:与药物损伤的DNA结合与酿酒酵母中增强的细胞毒性相关。
Mol Cell Biol. 1994 Dec;14(12):8071-7. doi: 10.1128/mcb.14.12.8071-8077.1994.
8
HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.HMG结构域蛋白可特异性抑制人切除核酸酶对抗癌药物顺铂主要DNA加合物的修复。
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10394-8. doi: 10.1073/pnas.91.22.10394.
9
Designing steroid receptor-based radiotracers to image breast and prostate tumors.设计基于类固醇受体的放射性示踪剂以对乳腺和前列腺肿瘤进行成像。
J Nucl Med. 1995 Jun;36(6 Suppl):8S-13S.
10
Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide.转录因子Sp1与经苯并[a]芘二醇环氧化物修饰的DNA中非靶位点的结合。
Carcinogenesis. 1995 May;16(5):975-83. doi: 10.1093/carcin/16.5.975.